share_log

What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?

What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?

Avanos Medical, Inc.(紐交所:AVNS)的股價怎麼樣?
Simply Wall St ·  12/18 21:01

While Avanos Medical, Inc. (NYSE:AVNS) might not have the largest market cap around , it received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$24.69 at one point, and dropping to the lows of US$17.02. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Avanos Medical's current trading price of US$17.02 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Avanos Medical's outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

儘管Avanos Medical, Inc. (紐交所:AVNS)的市值可能不是最大的,但在過去幾個月裏,它在紐交所的價格波動引起了很多關注,一度上漲到24.69美元,隨後又下跌到17.02美元的低點。一些股價波動可能爲投資者提供了更好的機會進入股票市場,並可能以較低的價格買入。一個需要回答的問題是,Avanos Medical目前的交易價格17.02美元是否反映了這家小盤股的實際價值?或者它是否被低估,爲我們提供了買入的機會?讓我們根據最新的財務數據來看看Avanos Medical的前景和價值,看看是否有任何催化劑能導致價格變化。

Is Avanos Medical Still Cheap?

Avanos Medical現在還便宜嗎?

The share price seems sensible at the moment according to our price multiple model, where we compare the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that Avanos Medical's ratio of 33.85x is trading slightly below its industry peers' ratio of 35.97x, which means if you buy Avanos Medical today, you'd be paying a decent price for it. And if you believe Avanos Medical should be trading in this range, then there isn't much room for the share price to grow beyond the levels of other industry peers over the long-term. In addition to this, it seems like Avanos Medical's share price is quite stable, which could mean there may be less chances to buy low in the future now that it's trading around the price multiples of other industry peers. This is because the stock is less volatile than the wider market given its low beta.

根據我們的價格倍數模型,目前的股價似乎是合理的,我們將公司的市盈率與行業平均水平進行了比較。在這種情況下,由於沒有足夠的信息可靠預測股票的現金流,我們使用了市盈率(市盈率)。我們發現Avanos Medical的市盈率爲33.85倍,略低於其行業同行的35.97倍,意味着如果您今天買入Avanos Medical,您將爲其支付一個合理的價格。如果您認爲Avanos Medical應該在這個區間交易,那麼股價就沒有太大的空間在長期內超越其他行業同行。此外,Avanos Medical的股價似乎相當穩定,這可能意味着在未來買入低價的機會減少,因爲它現在正交易在其他行業同行的價格倍數附近。這是因爲該股票的波動性低於大盤,β值較低。

What does the future of Avanos Medical look like?

Avanos Medical的未來看起來如何?

big
NYSE:AVNS Earnings and Revenue Growth December 18th 2024
紐交所:AVNS 盈利與營業收入增長 2024年12月18日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Avanos Medical's revenue growth are expected to be in the teens in the upcoming years, indicating a solid future ahead. Unless expenses grow at the same level, or higher, this top-line growth should lead to robust cash flows, feeding into a higher share value.

尋找投資組合增長的投資者可能在購買其股票之前需要考慮一家公司前景。儘管價值投資者會爭辯說相對價格的內在價值最爲重要,但更吸引人的投資論點是以廉價獲取高增長潛力。預計Avanos Medical的營業收入增長在未來幾年將處於十幾個百分點,這顯示了良好的未來前景。除非支出以相同水平或更高水平增長,否則這種收入增長應該會導致強勁的現金流,從而推動股價上漲。

What This Means For You

這對你意味着什麼

Are you a shareholder? It seems like the market has already priced in AVNS's positive outlook, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at AVNS? Will you have enough conviction to buy should the price fluctuate below the industry PE ratio?

你是股東嗎?看起來市場已經考慮到了AVNS的積極前景,股票交易價格大約在行業的價格區間。不過,還有其他重要因素我們今天沒有考慮,比如公司的財務實力。這些因素自從你上次查看AVNS以來有改變嗎?如果價格波動低於行業市盈率,你會有足夠的信心去買入嗎?

Are you a potential investor? If you've been keeping tabs on AVNS, now may not be the most optimal time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for AVNS, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

你是潛在投資者嗎?如果你一直在關注AVNS,現在可能不是買入的最佳時機,因爲它的交易價格大約在行業的價格區間。不過,樂觀的預期對AVNS來說是一個積極信號,這意味着值得深入考慮其他因素,比如資產負債表的強勁,以便在下次價格下跌時抓住機會。

So while earnings quality is important, it's equally important to consider the risks facing Avanos Medical at this point in time. Case in point: We've spotted 1 warning sign for Avanos Medical you should be aware of.

因此,雖然盈利質量很重要,但同樣重要的是考慮當前Avanos Medical面臨的風險。比如,我們發現了一個你應該注意的Avanos Medical的警示信號。

If you are no longer interested in Avanos Medical, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果你對Avanos Medical不再感興趣,可以使用我們的免費平台查看我們列出的50多隻具有高增長潛力的其他股票。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論